Boston Scientific to pay Johnson & Johnson $1.73 billion to settle 2 suits over stents

Boston Scientific to pay JNJ $1.73B in settlement

NEW YORK — Johnson & Johnson says Boston Scientific will pay the company $1.73 billion to settle two suits related to patents for stents.

Boston Scientific Corp. will pay New Brunswick, N.J. Johnson & Johnson’s Cordis unit $1 billion today and $725 million next January.

Other litigation between the companies remains, including the Cordis lawsuits against Natick, Mass.-based Boston Scientific’s Promus stent products.

Stents are mesh-wire tubes used to hold arteries open after they are surgically cleared of blockages.